Cardiovascular Diseases — Effects of Oral Antioxidant Cocktail in Cardiovascular Disease Patients
Citation(s)
Burton GJ, Jauniaux E Oxidative stress. Best Pract Res Clin Obstet Gynaecol. 2011 Jun;25(3):287-99. doi: 10.1016/j.bpobgyn.2010.10.016. Epub 2010 Dec 3.
Dahlof B Cardiovascular disease risk factors: epidemiology and risk assessment. Am J Cardiol. 2010 Jan 4;105(1 Suppl):3A-9A. doi: 10.1016/j.amjcard.2009.10.007.
Deanfield JE, Halcox JP, Rabelink TJ Endothelial function and dysfunction: testing and clinical relevance. Circulation. 2007 Mar 13;115(10):1285-95. doi: 10.1161/CIRCULATIONAHA.106.652859. No abstract available.
Frei B Reactive oxygen species and antioxidant vitamins: mechanisms of action. Am J Med. 1994 Sep 26;97(3A):5S-13S; discussion 22S-28S. doi: 10.1016/0002-9343(94)90292-5.
Hagberg JM, Park JJ, Brown MD The role of exercise training in the treatment of hypertension: an update. Sports Med. 2000 Sep;30(3):193-206. doi: 10.2165/00007256-200030030-00004.
Incalza MA, D'Oria R, Natalicchio A, Perrini S, Laviola L, Giorgino F Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases. Vascul Pharmacol. 2018 Jan;100:1-19. doi: 10.1016/j.vph.2017.05.005. Epub 2017 Jun 1.
Nakano M, Murayama Y, Hu L, Ikemoto K, Uetake T, Sakatani K Effects of Antioxidant Supplements (BioPQQ) on Cerebral Blood Flow and Oxygen Metabolism in the Prefrontal Cortex. Adv Exp Med Biol. 2016;923:215-222. doi: 10.1007/978-3-319-38810-6_29.
Ogita H, Liao J Endothelial function and oxidative stress. Endothelium. 2004 Mar-Apr;11(2):123-32. doi: 10.1080/10623320490482664.
Schulz E, Gori T, Munzel T Oxidative stress and endothelial dysfunction in hypertension. Hypertens Res. 2011 Jun;34(6):665-73. doi: 10.1038/hr.2011.39. Epub 2011 Apr 21.
Szocs K Endothelial dysfunction and reactive oxygen species production in ischemia/reperfusion and nitrate tolerance. Gen Physiol Biophys. 2004 Sep;23(3):265-95.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
